MYCN and neoplasm: We have recently shown that, because of MYCN-mediated metabolic reprogramming, MYCN-amplified tumor cells are increasingly dependent on key metabolic pathways for proliferation and survival, such as the serine–glycine–one-carbon metabolic network [9, 10].